Production (Stage)
Medtronic plc
MDT
$89.92
$0.520.58%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
04/25/2025 | 01/24/2025 | 10/25/2024 | 07/26/2024 | 04/26/2024 | |
---|---|---|---|---|---|
Revenue | 3.62% | 2.72% | 3.25% | 3.23% | 3.64% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 3.62% | 2.72% | 3.25% | 3.23% | 3.64% |
Cost of Revenue | 4.66% | 3.13% | 4.09% | 4.58% | 4.41% |
Gross Profit | 3.08% | 2.50% | 2.81% | 2.53% | 3.24% |
SG&A Expenses | 3.93% | 3.61% | 3.63% | 3.33% | 3.35% |
Depreciation & Amortization | 6.80% | -2.00% | -2.52% | -1.58% | -0.35% |
Other Operating Expenses | 28.49% | -75.41% | -34.58% | -44.36% | -63.62% |
Total Operating Expenses | 4.17% | 1.65% | 2.72% | 2.68% | 2.05% |
Operating Income | 1.39% | 7.17% | 5.51% | 5.57% | 10.73% |
Income Before Tax | 16.33% | -5.57% | -5.12% | -10.99% | -9.76% |
Income Tax Expenses | -17.37% | -28.02% | -36.41% | -48.90% | -28.18% |
Earnings from Continuing Operations | 26.65% | 1.32% | 4.83% | 8.42% | -2.06% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -3.57% | 9.38% | -52.17% | 3.45% | -12.00% |
Net Income | 26.82% | 1.40% | 4.56% | 8.51% | -2.16% |
EBIT | 1.39% | 7.17% | 5.51% | 5.57% | 10.73% |
EBITDA | 1.68% | 5.06% | 3.11% | 3.09% | 6.69% |
EPS Basic | 31.15% | 4.47% | 6.55% | 9.46% | -2.06% |
Normalized Basic EPS | 5.12% | -1.21% | -0.41% | -0.80% | 3.61% |
EPS Diluted | 31.69% | 4.68% | 6.49% | 9.20% | -2.47% |
Normalized Diluted EPS | 4.97% | -1.31% | -0.48% | -0.79% | 3.64% |
Average Basic Shares Outstanding | -3.24% | -2.64% | -1.76% | -0.85% | -0.13% |
Average Diluted Shares Outstanding | -3.11% | -2.54% | -1.69% | -0.85% | -0.16% |
Dividend Per Share | 1.45% | 1.45% | 1.46% | 1.47% | 1.47% |
Payout Ratio | -0.23% | -0.03% | -0.05% | -0.07% | 0.04% |